These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 8908077

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cyclosporine therapy in pancreas transplantation.
    Davidson I, Lu C, Melone D, Risser R.
    Transplant Proc; 1996 Aug; 28(4):2134-5. PubMed ID: 8769179
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Intraoperative high-dose anti-T-lymphocyte globulin bolus in addition to triple-drug therapy improves kidney graft survival.
    Kaden J, May G, Müller P, Groth J, Strobelt V, Eger E, Wohlfahrt L.
    Transplant Proc; 1995 Feb; 27(1):1060-1. PubMed ID: 7878804
    [No Abstract] [Full Text] [Related]

  • 10. Quadruple immunotherapy will promise excellent graft survival in cadaveric renal transplants using cardiac arrest donor grafts.
    Hoshinaga K, Shiroki R, Higuchi T, Horiba Y, Yanaoka M, Naide Y.
    Transplant Proc; 1996 Jun; 28(3):1591-3. PubMed ID: 8658798
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparative analysis of azathioprine versus cyclosporine-based therapy in primary haplo-identical live-donor kidney transplantation: a 20-year experience.
    Gheith OA, Bakr MA, Fouda MA, Shokeir AA, Sobh M, Ghoneim M.
    Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):564-70. PubMed ID: 18580014
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prospective randomized study of triple vs conventional immunosuppression in living donor kidney transplantation.
    Ghoneim MA, Sobh MA, Shokeir AA, Bakr MA, el-Sherif A, Foda MA.
    Transplant Proc; 1993 Jun; 25(3):2243-5. PubMed ID: 8516887
    [No Abstract] [Full Text] [Related]

  • 18. Long-term results and risk factors of quadruple immunosuppression in renal transplantation.
    Hiesse C, Kriaa F, Eschwege P, Boubenider S, Marchand S, Benoit G, Charpentier B.
    Transplant Proc; 1999 Jun; 31(1-2):1111-2. PubMed ID: 10083496
    [No Abstract] [Full Text] [Related]

  • 19. Impact of HLA matching, type of crossmatch, and immunosuppressive therapy on primary pediatric cadaver renal allograft survival.
    Kerman RH, Sullivan EK, Tejani A.
    Transplant Proc; 1995 Feb; 27(1):656-7. PubMed ID: 7879133
    [No Abstract] [Full Text] [Related]

  • 20. Beneficial effect of concomitant induction with antilymphoblast globulin, cyclosporine, and steroids on long-term renal allograft outcome.
    Koga A, Moreso FJ, Seron D, Gil-Vernet S, Cruzado JM, Castelao AM, Grinyó JM.
    Transplant Proc; 2004 Jun; 36(5):1305-7. PubMed ID: 15251318
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.